Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
NEW YORK, May 16, 2017 -- Progyny, the leading fertility benefits company, today announced that it was named #13 on CNBC’s fifth annual Disruptor 50 List. The rapidly growing company secured its spot alongside companies such as Airbnb, Lyft, and WeWork.
The Disruptor 50 is an annual list of private companies that are shaking up the landscape and threatening the status quo in their respective industries. CNBC selects companies from a list of hundreds nominated by venture capitalists, industry analysts, and beat reporters. Disruptor 50 companies are widely regarded as poised for substantial growth.
Progyny’s employer offering is a cutting-edge women’s health benefit that supports fertility preservation and comprehensive family building. The program includes fertility benefits, such as IVF and egg freezing, and also support for individuals needing to build their families through surrogacy and adoption. Progyny’s fertility benefits combine service, science and data to optimize the clinical outcomes of fertility treatments, including increased IVF success, reduced time to pregnancy, and a reduced rate of multiples (twins), which is often a key driver of high-risk obstetric and NICU costs. Employer’s utilizing Progyny’s programs promote a workplace culture of supporting women and families. Progyny’s vision is to ensure that anyone who wants to have a child, can have one.
“Today is a proud day for Progyny. For the past year and a half, Progyny’s business has grown rapidly as more and more large employers are looking to adopt fertility benefits in order to attract and retain top talent, show appreciation for their female workforce, and highlight the importance of family building as a core value for their organizations,” said David Schlanger, Progyny CEO. “This accolade from CNBC further substantiates the interest in the fertility industry as a whole and our unique way of helping employees navigate this often opaque yet important benefit.”
For more information visit, www.Progyny.com. For the full list of CNBC Disruptor 50 companies, please visit the CNBC website.
About Progyny:
Progyny is a leading fertility benefits company that combines service, science, technology and data to provide comprehensive value based fertility solutions for self-insured employers. Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.
Media Contact: Heather Aponte [email protected] Phone: 646-965-0695
